CLL and Non-Hodgkin Lymphoma, What are the risks and bene...

CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
Cancer Photo

Cancer
3 años 150 Visitas
Categoría:
Descripción:
CLL and non-hodgkin lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib